NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NHLBI E-142-2021-0-US-02 METHODS AND SYSTEMS FOR MAXWELL COMPENSATION FOR SPIN-ECHO TRAIN IMAGING US ORD 17/732,155 11860258 Issued PDF
NIDA E-122-2022-0-US-02 ANTIBODIES AGAINST FENTANYL AND FENTANYL ANALOGS US ORD 17/661,160 Pending
NINDS E-113-2022-0-US-01 RECOMBINANT POLYPEPTIDES COMPRISING SINGLE-DOMAIN ANTIBODIES TARGETING HERV-K SUBTYPE HML-2 US 63/335,824 Expired
NIDDK E-126-2021-0-PCT-02 Purine Nucleosides, Their Intermediates, And Methods Of Preparation Thereof PCT PCT PCT/US2022/071971 Expired
NIAID E-239-2020-0-PCT-02 RECOMBINANT CHIMERIC BOVINE/HUMAN PARAINFLUENZA VIRUS 3 EXPRESSING SARS-COV-2 SPIKE PROTEIN AND ITS USE PCT PCT PCT/US2022/026576 Expired
NIBIB E-118-2022-0-US-01 MICROFLUIDIC DEVICES FOR EVALUATING FIBROSIS IN MATERIAL IMPLANTATION
AND CANCER
US 63/335,527 Expired
NCI E-127-2022-0-US-01 COMPOSITIONS AND METHODS FOR ASSEMBLING DECELLULARIZED TISSUE EXTRACELLULAR MATRIX IN THREE DIMENSIONAL SPHEROIDS US 63/335,555 Expired
NEI E-227-2018-0-CN-06 Druggable Taraget to Treat Retinal Degeneration CN National Stage 202080075532.5 Pending
NIAID E-221-2022-2-PC-01 LENTIVIRAL VECTORS USEFUL FOR THE TREATMENT OF DISEASE PCT PCT PCT/US2022/026409 Expired
NHGRI E-175-2019-0-EP-03 SYNTHETIC GENES FOR THE TREATMENT OF PROPIONIC ACIDEMIA CAUSED BY MUTATIONS IN PROPIONYL-COA CARBOXYLASE BETA EP National Stage 20804709.2 Pending
NIAID E-221-2022-2-CN-01 LENTIVIRAL VECTORS USEFUL FOR THE TREATMENT OF DISEASE CN National Stage 202280037491.X Pending
NIDCR E-196-2021-0-US-01 Lens Array Based Imaging System with Improved Field of View US 63/334,399 Expired
NIA E-062-2021-0-PCT-02 HUMAN INSULIN C-ALPHA-PEPTIDES AND METHODS OF USE PCT PCT PCT/US2022/025764 Expired
NCI E-185-2019-0-US-08 High Affinity Nanobodies Targeting B7-H3 (CD276) For Treating Multiple Solid Tumors US National Stage 17/770,940 Pending
NIAID E-202-2018-0-US-03 PST2238 (Rostafuroxin) As An Antiviral Drug Against Respiratory Syncytial Virus (RSV) US DIV 17/725,331 Abandoned
NIAID E-139-2006-0-US-71 DEVELOPMENT OF DENGUE VIRUS VACCINE COMPONENTS US CON 17/724,037 11746335 Issued PDF
NCI E-065-2015-0-US-14 GRIFFITHSIN MUTANTS US CON 17/724,342 Pending
NCI E-191-2019-0-PCT-02 HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH Q61K MUTATION PCT PCT PCT/US2022/025177 Expired
NIAID E-090-2021-0-PC-01 Bispecific Antibodies To Ebola Virus Glycoprotein And Their Use PCT PCT PCT/US2023/065775 Expired
NIAID E-216-2014-0-US-17 RECOMBINANT RESPIRATORY SYNCYTIAL VIRUS STRAINS WITH MUTATIONS IN THE M2-2 ORF PROVIDING A RANGE OF ATTENUATION PHENOTYPES US CON 17/721,188 Abandoned
NIAID E-090-2021-0-US-01 Bispecific Antibodies To Ebola Virus Glycoprotein And Their Use US 63/330,877 Expired
NIBIB E-005-2012-3-CN-13 MULTI-FOCAL STRUCTURED ILLUMINATION MICROSCOPY SYSTEMS AND METHODS CN DIV 202210413867.4 Pending
NEI E-227-2018-0-ID-08 Druggable Taraget to Treat Retinal Degeneration ID National Stage P-00202204386 Pending
NCI E-174-2018-2-GB-18 TUMOR INFILTRATING LYMPHOCYTES AND METHODS OF THERAPY GB DIV 2205417.5 Issued
NIA E-151-2017-0-US-12 FATTY ACID DERIVATIVES AND THEIR USE US DIV 17/718,965 Pending
NIAID E-089-2022-0-US-01 PREFUSION-STABILIZED LASSA VIRUS GLYCOPROTEIN COMPLEX AND ITS USE US 63/329,886 Expired
NCI E-190-2014-0-AU-46 VIRUS-LIKE PARTICLE CONJUGATES FOR DIAGNOSIS AND TREATMENT OF TUMORS AU DIV 2022202408 Pending
NCI E-030-2022-0-EP-01 Anti-Viral Compositions And Methods Of Making And Using EP National Stage 20862862.8 Pending
NCI E-139-2015-0-US-05 FIXATIVES AND METHODS OF USE US DIV 17/716,606 Pending
NEI E-227-2018-0-IN-09 Druggable Taraget to Treat Retinal Degeneration IN National Stage 202247021119 Pending
NCI E-230-2012-0-HK-68 T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3 HK CN 42022051280.0 Pending
NHLBI E-036-2022-0-US-01 SABRE CATALYSTS CONTAINING FLUORINATED CARBON CHAINS FOR DELIVERY OF METAL-FREE MRI CONTRAST AGENTS US 63/328,545 Expired
NHLBI E-052-2022-0-US-01 INFUSION DEVICE FOR THE PREPARATION AND DELIVERY OF MRI PROBES US 63/328,556 Expired
NIAID E-060-2022-0-US-01 BETA GLOBIN MIMETIC PEPTIDES AND THEIR USE US 63/328,615 Expired
NIDDK E-138-2017-0-JP-20 COMPOUNDS AND METHODS FOR TREATING NEUROLOGICAL AND CARDIOVASCULAR CONDITIONS JP DIV 2022-63285 Pending
NCI E-174-2019-0-US-04 A VIRAL EXPOSURE SIGNATURE FOR DETECTION OF EARLY STAGE HEPATOCELLULAR CARCINOMA US National Stage 17/766,015 Pending
NHGRI E-175-2019-0-US-04 SYNTHETIC GENES FOR THE TREATMENT OF PROPIONIC ACIDEMIA CAUSED BY MUTATIONS IN PROPIONYL-COA CARBOXYLASE BETA US National Stage 17/766,067 Pending
NHLBI E-143-2021-2-US-01 Transmural Refinement Of Inner Curvature Charge Concentration Device For Tissue Laceration US CIP 17/710,149 Pending
NCI E-233-2014-0-EP-10 Methods of Isolating T Cell Receptors Having Antigenic Specificity for a Cancer-Specific Mutation EP DIV 22166152.3 Pending
NEI E-227-2018-0-EP-07 Druggable Taraget to Treat Retinal Degeneration EP National Stage 20780525.0 Pending
NLM E-023-2023-0-US-01 Methylation-Dependent Enrichment Of DNA By Organism Of Origin US 63/326,073 Expired
NIAID E-233-2017-0-US-06 ASSAY FOR THE DETECTION OF ALPHA-SYNUCLEIN SEEDING ACTIVITY ASSOCIATED WITH SYNUCLEINOPATHIES US CON 17/708,560 12105101 Issued PDF
NCATS E-042-2022-0-US-01 SYNTHESIS OF DOPAMINE D3 RECEPTOR SELECTIVE ANTAGONISTS/PARTIAL AGONISTS US 63/325,313 Expired
NCI E-021-2015-0-EP-36 Anti-CD70 Chimeric Antigen Receptors EP DIV 22164990.8 Pending
NIDDK E-067-2022-0-US-01 A3 ADENOSINE RECEPTOR POSITIVE ALLOSTERIC MODULATORS US 63/325,095 Expired
NCATS E-060-2017-3-US-03 Compositions And Methods For Identifying And Treating Dystonia Disorders US CON 17/706,461 Pending
NIAID E-073-2022-0-US-01 NEUTRALIZING ANTIBODIES TO HIV-1 ENV AND THEIR USE US 63/324,152 Expired
NIAID E-079-2022-0-US-01 BASE-COVERED HIV-1 ENVELOPE ECTODOMAINS AND THEIR USE US 63/324,121 Expired
NIAID E-080-2022-0-US-01 BISPECIFIC ANTIBODIES TO HIV-1 ENV AND THEIR USE US 63/324,037 Expired
NIDCR E-034-2021-0-US-01 Regulation Of Connexin Channels In The Inner Ear For Treating Deafness And Hearing Loss US 63/323,726 Expired